Rabies virus glycoprotein — Drug Target
All drugs that target Rabies virus glycoprotein — marketed and clinical-stage. Includes 8 drug classes acting on this target.
Drug classes
Rabies vaccine · Rabies immunoglobulin (human) · Passive immunizing agent; immunoglobulin · Vaccine + Immunoglobulin combination · Inactivated viral vaccine · Human rabies immunoglobulin (HRIG) · Immunoglobulin (passive immunization) · Monoclonal antibody immunoglobulin (rabies-specific)
Marketed (3)
- Rabivax-S · University of Oxford · Rabies vaccine · Infectious Disease / Immunology
Rabivax-S is a recombinant rabies virus vaccine that stimulates immune responses against rabies virus through viral glycoprotein antigens. - HyperRAB · Bio Products Laboratory · Rabies immunoglobulin (human) · Infectious Disease / Immunology
HyperRAB is a rabies immunoglobulin (human) that provides passive immunity by supplying antibodies against rabies virus. - Rabies immune globulin (human) · Sanofi Pasteur, a Sanofi Company · Passive immunizing agent; immunoglobulin · Immunology; Infectious Disease
Rabies immune globulin provides passive immunization by supplying human antibodies that neutralize rabies virus and prevent its progression to the central nervous system.
Phase 3 pipeline (7)
- Rabies vaccines + Rabies immunoglobulins · Novartis · Vaccine + Immunoglobulin combination · Infectious Disease / Immunology
Rabies vaccines stimulate immune response against rabies virus, while rabies immunoglobulins provide immediate passive immunity through pre-formed antibodies. - HDCV Comparator · Wilbur Chen, MD, MS · Inactivated viral vaccine · Immunology / Infectious Disease
HDCV (Human Diploid Cell Vaccine) is a rabies vaccine that stimulates the immune system to produce antibodies against rabies virus. - KamRAB - HRIG · Kamada, Ltd. · Human rabies immunoglobulin (HRIG) · Infectious Disease / Immunology
KamRAB is a human rabies immunoglobulin (HRIG) that provides passive immunity by supplying antibodies against rabies virus. - Human rabies immunoglobulins · Sanofi Pasteur, a Sanofi Company · Immunoglobulin (passive immunization) · Infectious Disease / Immunology
Human rabies immunoglobulins provide passive immunity by supplying antibodies that neutralize rabies virus and prevent its progression to the central nervous system. - Purified Vero Rabies Vaccine · Sanofi Pasteur, a Sanofi Company · Inactivated viral vaccine · Immunology / Infectious Disease
Purified Vero Rabies Vaccine stimulates the immune system to produce antibodies and cellular immunity against rabies virus by presenting inactivated rabies antigen. - PVRV and pERIG Favirab® · Sanofi Pasteur, a Sanofi Company · Monoclonal antibody immunoglobulin (rabies-specific) · Infectious Disease / Virology
PVRV and pERIG Favirab® are rabies immunoglobulins that provide passive post-exposure prophylaxis by neutralizing rabies virus through direct antibody binding. - Cell-culture rabies vaccine · GlaxoSmithKline · Inactivated viral vaccine · Infectious Disease / Immunology
A cell-culture derived rabies vaccine that stimulates the immune system to produce antibodies and cellular immunity against rabies virus.